SCHEMBL31111757

SCHEMBL31111757

CCC(c1cccc(-c2nc(C)sc2-c2ccnc(Cl)n2)c1F)S(N)(=O)=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 15/20 0.38
NR1I2 O75469 8/20 0.38
CDK4 P11802 3/20 0.38
CDK2 P24941 3/20 0.38
PLK4 O00444 1/20 0.38
EPHB6 O15197 1/20 0.38
RIPK2 O43353 1/20 0.38
JAK2 O60674 1/20 0.38
ULK1 O75385 1/20 0.38
ERN1 O75460 1/20 0.38
PRKD3 O94806 1/20 0.38
ABL1 P00519 1/20 0.38
KRAS P01116 1/20 0.38
RAF1 P04049 1/20 0.38
LCK P06239 1/20 0.38
FYN P06241 1/20 0.38
CDK1 P06493 1/20 0.38
YES1 P07947 1/20 0.38
LYN P07948 1/20 0.38
MET P08581 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31111705 0.91 BRAF (0.38) BRAFNR1I2CDK4CDK2PLK4
SCHEMBL1872919 0.89 BRAF (0.47) BRAFNR1I2CDK4CDK2PLK4
SCHEMBL1873051 0.89 BRAF (0.51) BRAFNR1I2CDK4CDK2PLK4
SCHEMBL1875091 0.86 BRAF (0.46) BRAFNR1I2
SCHEMBL1870216 0.86 BRAF (0.45) BRAFNR1I2CDK4CDK2PLK4
SCHEMBL1868490 0.85 BRAF (0.37) BRAFNR1I2CDK4CDK2PLK4
SCHEMBL1870842 0.84 EGFR (0.37) BRAFNR1I2CDK4CDK2PLK4
SCHEMBL1866612 0.84 BRAF (0.42) BRAFNR1I2
SCHEMBL1872504 0.84 BRAF (0.42) BRAFNR1I2CDK4CDK2PLK4
SCHEMBL1873118 0.84 BRAF (0.46) BRAFNR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024227104-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING BRAF VIA UBIQUITIN PROTEOSOME PATHWAY NURIX THERAPEUTICS, INC. (US) 2024-10-31 WO disclosed